TARR MARK J (President & CEO) sold 28.5% of their position (150K shares) of ENCOMPASS HEALTH CORP on the open market
Open‑market sale worth $16.75M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Encompass Health Common Stock
Shares
−16.22K
Price / share
$108.03
Trade value
$1.75M
% of position
Encompass Health Common Stock
Shares
−13.23K
Price / share
$108.80
Trade value
$1.44M
% of position
Encompass Health Common Stock
Shares
−15.58K
Price / share
$110.07
Trade value
$1.72M
% of position
Encompass Health Common Stock
Shares
−10.95K
Price / share
$110.92
Trade value
$1.22M
% of position
Encompass Health Common Stock
Shares
−6.06K
Price / share
$111.89
Trade value
$677.72K
% of position
Encompass Health Common Stock
Shares
−87.75K
Price / share
$113.09
Trade value
$9.92M
% of position
Encompass Health Common Stock
Shares
−213.00
Price / share
$113.58
Trade value
$24.19K
% of position
Net shares
−150K
Net value
-$16.75M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Encompass Health Common Stock Direct | 2/11/2026 | S · Sale | −16.22K | $108.03 | $1.75M | 3.1% | 527.07K | 510.85K |
| Encompass Health Common Stock Direct | 2/11/2026 | S · Sale | −13.23K | $108.80 | $1.44M | 2.6% | 510.85K | 497.62K |
| Encompass Health Common Stock Direct | 2/11/2026 | S · Sale | −15.58K | $110.07 | $1.72M | 3.1% | 497.62K | 482.04K |
| Encompass Health Common Stock Direct | 2/11/2026 | S · Sale | −10.95K | $110.92 | $1.22M | 2.3% | 482.04K | 471.08K |
| Encompass Health Common Stock Direct | 2/11/2026 | S · Sale | −6.06K | $111.89 | $677.72K | 1.3% | 471.08K | 465.03K |
| Encompass Health Common Stock Direct | 2/11/2026 | S · Sale | −87.75K | $113.09 | $9.92M | 18.9% | 465.03K | 377.28K |
| Encompass Health Common Stock Direct | 2/11/2026 | S · Sale | −213.00 | $113.58 | $24.19K | 0.1% | 377.28K | 377.07K |
| Total | −150K | -$16.75M | ||||||